In March 2010, I was diagnosed with Stage IIIB Liver Cancer and given six months to live…

Hi everyone, just to let you know that I'm gone this afternoon, Mmmkay! Hunt - July 6, 2011 @ 2:55 p.m.

Treatment and Labs

CURRENT TREATMENTS

Acupuncture and Chinese Herbs
with  Christy Mahoney, L.Ac., MS, FABORM of  
Dragonwell Chinese Medicine and
KW Botanicals 

Weekly acupuncture session started March 04, 2011 plus

33. 05/17/11   Started Chinese Herbs tincture 3 tsp 3 times a day
34. 05/19/11   Increased Chinese Herbs tincture to 3 tsp 4 times a day
35. 05/20/11   Added Cordyceps 2 capsules twice a day
36. 05/23/11   Chinese Herbs tincture to full dose 4 tsp 4 times



Medical Qigong 
with Vadim Derevyanko of  
Chinese Medicine Bodywork

06/05/11   Started 1st Medical Qigong session


___________________________________

PAST TREATMENTS

Kaiser Permanente, Vallejo, California

1.   03/31/10 Diagnosed with liver cancer stage IIIB
2.   04/30/10 Started Nexavar 


VA Medical Center, San Francisco, California

3.   09/01/10 Stopped Nexavar: C-MET clinical trial requirements
4.   09/30/10 Not qualified for UCSF C-MET inhibitor clinical trial 
5.   10/20/10 Started CAPOX (Capecitabine plus Oxaliplatin)
6.   11/01/10 Stopped CAPOX: Pain worsen


Dr. Burzynski's Clinic, Houston, Texas

7.   12/14/10 Started Sodium Phenylbutyrate
8.   12/16/10 Started Tykerb (Lapatinib)
9.   12/18/10 Started first Herceptin (Trastuzumab) IV infusion
10. 12/21/10 Started Zolinza (Vorinostat)
11. 12/27/10 Stopped Zolinza (Vorinostat): Liver enzymes went up
12. 12/28/10 Stopped Tykerb (Lapatinib): Liver enzymes went up
13. 12/28/10 Second Herceptin (Trastuzumab) IV infusion
14. 01/19/11 Re-started Tykerb (Lapatinib)
15. 01/27/11 Stopped Tykerb (Lapatinib)
16. 01/31/11 Stopped Sodium Phenylbutyrate


Dr. Richard Kunin, San Francisco, California
17. 02/10/11 1st  IV Infusion of Vitamins  & Supplements Regimen
18. 02/17/11 2nd IV Infusion of Vitamins  
19. 02/24/11 3rd IV Infusion of Vitamins 
20. 03/01/11 4th IV Infusion of Vitamins 
21. 03/08/11 5th IV Infusion of Vitamins
22. 03/15/11 6th IV Infusion of Vitamins
23. 03/17/11 7th IV Infusion of Vitamins
24. 03/22/11 8th IV Infusion of Vitamins
25. 03/31/11 9th IV Infusion of Vitamins
26. 04/05/11 10th IV Infusion of Vitamins & 2nd Suppl. Regimen
27. 04/12/11 11th IV Infusion of Vitamins
28. 04/19/11 12th IV Infusion of Vitamins
29. 05/05/11 13th IV Infusion of Vitamins & 3rd Suppl. Regimen
30. 05/07/11 Started Artemisinin  as 100mg twice a day
31. 05/10/11 Increased Artemisinin to 200mg twice a day
32. 05/12/11 Stopped Artemisinin due to pain worsen




_______________

Labs

Bilirubin, Total (mg/dL)

Standard Range 0.2 - 1.3

1.0    04/07/10      
1.0    04/19/10      
1.1    04/29/10      
1.8    11/02/11       
8.1    02/05/11       
2.8    02/27/11      
6.8    03/26/11         
11.2  05/15/11
10.5  05/22/11    

A bilirubin test measures the amount of bilirubin in a blood sample. Bilirubin is a brownish yellow substance found in bile. It is produced when the liver breaks down old red blood cells. Bilirubin is then removed from the body through the stool (feces) and gives stool its normal brown color.  Bilirubin circulates in the bloodstream in two forms:
  • Indirect (or unconjugated) bilirubin. This form of bilirubin does not dissolve in water (it is insoluble). Indirect bilirubin travels through the bloodstream to the liver, where it is changed into a soluble form (direct or conjugated).
  • Direct (or conjugated) bilirubin. Direct bilirubin dissolves in water (it is soluble) and is made by the liver from indirect bilirubin.
Total bilirubin and direct bilirubin levels are measured directly in the blood, whereas indirect bilirubin levels are derived from the total and direct bilirubin measurements.  When bilirubin levels are high, the skin and whites of the eyes may appear yellow (jaundice).  Jaundice may be caused by liver disease (hepatitis), blood disorders (hemolytic anemia), or blockage of the tubes (bile ducts) that allow bile to pass from the liver to the small intestine.

Source: Kaiser Permanente

_____________________________________________